Phenotypes and Lymphokine-Activated Killer Activity of Pleural Cavity Lymphocytes of Lung Cancer Patients Without Malignant Effusion

Chest - United States
doi 10.1378/chest.103.6.1732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.01-112 the Prognosis of Lung Cancer Patients With Unexpected Malignant Pleural Effusion and Without Pleural Dissemination Detected at Thoracotomy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Imaging Pattern of Radiolabelled Lymphokine-Activated Killer Cells in Patients With Metastatic Malignant Melanoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
1991English

PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion

2018English

Malignant Pleural Effusion

English

Malignant Pleural Effusion

2011English

Clinical Profile of Patients With Malignant Pleural Effusion

Journal of Medical Science And clinical Research
2017English

Management of Malignant Pleural Effusion

2013English

Clinical Role of F-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Lung Cancer and Suspected Malignant Pleural Effusion

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Pathogenesis and Management Options of Malignant Pleural Effusion:

Saudi Journal of Internal Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy